Literature DB >> 25428532

Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease.

Marianna Amboni1, Alessandro Tessitore, Fabrizio Esposito, Gabriella Santangelo, Marina Picillo, Carmine Vitale, Alfonso Giordano, Roberto Erro, Rosa de Micco, Daniele Corbo, Gioacchino Tedeschi, Paolo Barone.   

Abstract

Cognitive impairment is common in PD, even in early stages. The construct of mild cognitive impairment has been used to identify clinically evident cognitive impairment without functional decline in PD patients (PD-MCI). The aim of the present study was to investigate brain connectivity associated with PD-MCI through RS-fMRI. RS-fMRI at 3T was collected in 42 PD patients and 20 matched healthy controls. Among PD patients, 21 were classified as having MCI (PD-MCI) and 21 as cognitively unimpaired (PD-nMCI) based on criteria for possible PD-MCI (level I category). Single-subject and group-level ICA was used to investigate the integrity of brain networks related to cognition in PD patients with and without MCI. Image data processing and statistical analysis were performed in BrainVoyager QX. In addition, we used VBM to test whether functional connectivity differences were related to structural abnormalities. PD-nMCI and PD-MCI patients compared with controls showed decreased DMN connectivity. PD-MCI patients, but not PD-nMCI, compared with controls, showed decreased functional connectivity of bilateral prefrontal cortex within the frontoparietal network. The decreased prefrontal cortex connectivity correlated with cognitive parameters but not with clinical variables. VBM analysis did not reveal any difference in local gray matter between patients and controls. Our findings suggest that an altered DMN connectivity characterizes PD patients, regardless of cognitive status, whereas a functional disconnection of the frontoparietal network could be associated with MCI in PD in the absence of detectable structural changes.

Entities:  

Mesh:

Year:  2014        PMID: 25428532     DOI: 10.1007/s00415-014-7591-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  52 in total

1.  A normative study on visual reaction times and two Stroop colour-word tests.

Authors:  R Barbarotto; M Laiacona; R Frosio; M Vecchio; A Farinato; E Capitani
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Independent component model of the default-mode brain function: combining individual-level and population-level analyses in resting-state fMRI.

Authors:  Fabrizio Esposito; Adriana Aragri; Ilaria Pesaresi; Sossio Cirillo; Gioacchino Tedeschi; Elio Marciano; Rainer Goebel; Francesco Di Salle
Journal:  Magn Reson Imaging       Date:  2008-05-16       Impact factor: 2.546

Review 3.  Functional network disruption in the degenerative dementias.

Authors:  Michela Pievani; Willem de Haan; Tao Wu; William W Seeley; Giovanni B Frisoni
Journal:  Lancet Neurol       Date:  2011-07-21       Impact factor: 44.182

4.  Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus.

Authors:  Michael D Greicius; Benjamin H Flores; Vinod Menon; Gary H Glover; Hugh B Solvason; Heather Kenna; Allan L Reiss; Alan F Schatzberg
Journal:  Biol Psychiatry       Date:  2007-01-08       Impact factor: 13.382

5.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

8.  Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness.

Authors:  Joana Braga Pereira; Naroa Ibarretxe-Bilbao; Maria-Jose Marti; Yaroslau Compta; Carme Junqué; Nuria Bargallo; Eduardo Tolosa
Journal:  Hum Brain Mapp       Date:  2011-09-06       Impact factor: 5.038

9.  Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease.

Authors:  Atsuko Nagano-Saito; Claudine Habak; Beatriz Mejía-Constaín; Clotilde Degroot; Laura Monetta; Thomas Jubault; Christophe Bedetti; Anne-Louise Lafontaine; Sylvain Chouinard; Valérie Soland; Alain Ptito; Antonio P Strafella; Oury Monchi
Journal:  Neurobiol Aging       Date:  2013-08-07       Impact factor: 4.673

10.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501

View more
  56 in total

1.  The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Authors:  Dilek Betul Arslan; Hakan Gurvit; Ozan Genc; Ani Kicik; Kardelen Eryurek; Sevim Cengiz; Emel Erdogdu; Zerrin Yildirim; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Erdem Tuzun; Tamer Demiralp; Esin Ozturk-Isik
Journal:  J Neural Transm (Vienna)       Date:  2020-07-06       Impact factor: 3.575

2.  Stochastic Rank Aggregation for the Identification of Functional Neuromarkers.

Authors:  Paola Galdi; Michele Fratello; Francesca Trojsi; Antonio Russo; Gioacchino Tedeschi; Roberto Tagliaferri; Fabrizio Esposito
Journal:  Neuroinformatics       Date:  2019-10

3.  Can levodopa prevent cognitive decline in patients with Parkinson's disease?

Authors:  Masahiro Ikeda; Hiroshi Kataoka; Satoshi Ueno
Journal:  Am J Neurodegener Dis       Date:  2017-06-15

4.  Dynamic functional connectivity changes associated with dementia in Parkinson's disease.

Authors:  Eleonora Fiorenzato; Antonio P Strafella; Jinhee Kim; Roberta Schifano; Luca Weis; Angelo Antonini; Roberta Biundo
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

Review 5.  Advanced magnetic resonance imaging of neurodegenerative diseases.

Authors:  Federica Agosta; Sebastiano Galantucci; Massimo Filippi
Journal:  Neurol Sci       Date:  2016-11-15       Impact factor: 3.307

6.  Default-mode network connectivity in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson's disease.

Authors:  Yanbing Hou; Chunyan Luo; Jing Yang; Ruwei Ou; Wanglin Liu; Wei Song; Qiyong Gong; Huifang Shang
Journal:  J Neurol       Date:  2016-11-15       Impact factor: 4.849

7.  Emergent Functional Network Effects in Parkinson Disease.

Authors:  Caterina Gratton; Jonathan M Koller; William Shannon; Deanna J Greene; Baijayanta Maiti; Abraham Z Snyder; Steven E Petersen; Joel S Perlmutter; Meghan C Campbell
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

Review 8.  Connectivity Changes in Parkinson's Disease.

Authors:  Antonio Cerasa; Fabiana Novellino; Aldo Quattrone
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

9.  Parkinson's disease-related network topographies characterized with resting state functional MRI.

Authors:  An Vo; Wataru Sako; Koji Fujita; Shichun Peng; Paul J Mattis; Frank M Skidmore; Yilong Ma; Aziz M Uluğ; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2016-05-21       Impact factor: 5.038

10.  Gender-based analysis of cortical thickness and structural connectivity in Parkinson's disease.

Authors:  Santosh K Yadav; Nagarajan Kathiresan; Suyash Mohan; Georgia Vasileiou; Anup Singh; Deepak Kaura; Elias R Melhem; Rakesh K Gupta; Ena Wang; Francesco M Marincola; Arijitt Borthakur; Mohammad Haris
Journal:  J Neurol       Date:  2016-08-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.